Verition Fund Management LLC Edwards Lifesciences Corp Call Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.08 Million - $1.21 Million	12,800 Added 164.1%	20,600 $1.9 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $565,812 - $745,368	7,800 New	7,800 $745,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $195,384 - $226,392	2,400 New	2,400 $226,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $387,139 - $504,263	4,700 New	4,700 $388,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $752,550 - $1.12 Million	-8,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $683,132 - $859,878	6,700 Added 335.0%	8,700 $1.02 Million
Q4 2021 May 03, 2022	BUY	$106.37 - $130.68 $212,740 - $261,360	2,000 New	2,000 $259,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.